These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 28587059)
41. Chemotherapy-induced peripheral neuropathy in the adult. Saad M; Tafani C; Psimaras D; Ricard D Curr Opin Oncol; 2014 Nov; 26(6):634-41. PubMed ID: 25229554 [TBL] [Abstract][Full Text] [Related]
42. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population. Mols F; van de Poll-Franse LV; Vreugdenhil G; Beijers AJ; Kieffer JM; Aaronson NK; Husson O Eur J Cancer; 2016 Dec; 69():28-38. PubMed ID: 27814471 [TBL] [Abstract][Full Text] [Related]
43. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL; Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828 [TBL] [Abstract][Full Text] [Related]
45. Usability and Acceptability of a Web-Based Program for Chemotherapy-Induced Peripheral Neuropathy. Tofthagen C; Kip KE; Passmore D; Loy I; Berry DL Comput Inform Nurs; 2016 Jul; 34(7):322-9. PubMed ID: 27116414 [TBL] [Abstract][Full Text] [Related]
46. Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence. Balayssac D; Ferrier J; Descoeur J; Ling B; Pezet D; Eschalier A; Authier N Expert Opin Drug Saf; 2011 May; 10(3):407-17. PubMed ID: 21210753 [TBL] [Abstract][Full Text] [Related]
47. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies. Beijers AJ; Jongen JL; Vreugdenhil G Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810 [TBL] [Abstract][Full Text] [Related]
48. The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. Cavaletti G; Frigeni B; Lanzani F; Piatti M; Rota S; Briani C; Zara G; Plasmati R; Pastorelli F; Caraceni A; Pace A; Manicone M; Lissoni A; Colombo N; Bianchi G; Zanna C; J Peripher Nerv Syst; 2007 Sep; 12(3):210-5. PubMed ID: 17868248 [TBL] [Abstract][Full Text] [Related]
49. Chronic idiopathic axonal polyneuropathy and vitamin B6: a controlled population-based study. Visser NA; Notermans NC; Degen LA; de Kruijk JR; van den Berg LH; Vrancken AF J Peripher Nerv Syst; 2014 Jun; 19(2):136-44. PubMed ID: 24813907 [TBL] [Abstract][Full Text] [Related]
51. Background noise: the experience of chemotherapy-induced peripheral neuropathy. Bakitas MA Nurs Res; 2007; 56(5):323-31. PubMed ID: 17846553 [TBL] [Abstract][Full Text] [Related]
52. [Nursing care of chemotherapy-induced peripheral neuropathy]. Hsu SY; Lu CH; Chen SZ; Jane SW Hu Li Za Zhi; 2015 Apr; 62(2):84-8. PubMed ID: 25854951 [TBL] [Abstract][Full Text] [Related]
53. Vitamin D deficiency in patients with primary immune-mediated peripheral neuropathies. Elf K; Askmark H; Nygren I; Punga AR J Neurol Sci; 2014 Oct; 345(1-2):184-8. PubMed ID: 25115500 [TBL] [Abstract][Full Text] [Related]
54. A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer. Kuroi K; Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Watanabe T; Bain S; Hausheer FH Jpn J Clin Oncol; 2008 Nov; 38(11):748-54. PubMed ID: 18845520 [TBL] [Abstract][Full Text] [Related]
55. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy. Aziz MT; Good BL; Lowe DK Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146 [TBL] [Abstract][Full Text] [Related]
56. Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trial. Kottschade L; Loprinzi C; Rao R Support Cancer Ther; 2007 Sep; 4(4):251-3. PubMed ID: 18632525 [TBL] [Abstract][Full Text] [Related]
57. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Starobova H; Vetter I Front Mol Neurosci; 2017; 10():174. PubMed ID: 28620280 [TBL] [Abstract][Full Text] [Related]
58. B Vitamin Complex and Chemotherapy-Induced Peripheral Neuropathy. Schloss J; Colosimo M Curr Oncol Rep; 2017 Oct; 19(12):76. PubMed ID: 28983799 [TBL] [Abstract][Full Text] [Related]
59. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy. Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261 [TBL] [Abstract][Full Text] [Related]